227 related articles for article (PubMed ID: 36719241)
1. Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza.
Tjärnhage E; Brown D; Bogen B; Andersen TK; Grødeland G
J Virol; 2023 Feb; 97(2):e0169422. PubMed ID: 36719241
[TBL] [Abstract][Full Text] [Related]
2. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza.
Andersen TK; Zhou F; Cox R; Bogen B; Grødeland G
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931687
[TBL] [Abstract][Full Text] [Related]
3. A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge.
Shoji Y; Jones RM; Mett V; Chichester JA; Musiychuk K; Sun X; Tumpey TM; Green BJ; Shamloul M; Norikane J; Bi H; Hartman CE; Bottone C; Stewart M; Streatfield SJ; Yusibov V
Hum Vaccin Immunother; 2013 Mar; 9(3):553-60. PubMed ID: 23296194
[TBL] [Abstract][Full Text] [Related]
4. Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.
Florek KR; Weinfurter JT; Jegaskanda S; Brewoo JN; Powell TD; Young GR; Das SC; Hatta M; Broman KW; Hungnes O; Dudman SG; Kawaoka Y; Kent SJ; Stinchcomb DT; Osorio JE; Friedrich TC
J Virol; 2014 Nov; 88(22):13418-28. PubMed ID: 25210172
[TBL] [Abstract][Full Text] [Related]
5. Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin.
Brazzoli M; Magini D; Bonci A; Buccato S; Giovani C; Kratzer R; Zurli V; Mangiavacchi S; Casini D; Brito LM; De Gregorio E; Mason PW; Ulmer JB; Geall AJ; Bertholet S
J Virol; 2016 Jan; 90(1):332-44. PubMed ID: 26468547
[TBL] [Abstract][Full Text] [Related]
6. Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief.
Andersen TK; Bodin J; Oftung F; Bogen B; Mjaaland S; Grødeland G
Front Immunol; 2021; 12():747032. PubMed ID: 34691056
[TBL] [Abstract][Full Text] [Related]
7. Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.
Skarlupka AL; Bebin-Blackwell AG; Sumner SF; Ross TM
J Virol; 2021 Aug; 95(17):e0075921. PubMed ID: 34160258
[TBL] [Abstract][Full Text] [Related]
8. Induction of Cross-Reactive and Protective Antibody Responses After DNA Vaccination With MHCII-Targeted Stem Domain From Influenza Hemagglutinin.
Grødeland G; Baranowska-Hustad M; Abadejos J; Blane TR; Teijaro J; Nemazee D; Bogen B
Front Immunol; 2020; 11():431. PubMed ID: 32269566
[TBL] [Abstract][Full Text] [Related]
9. MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses.
Hessel A; Savidis-Dacho H; Coulibaly S; Portsmouth D; Kreil TR; Crowe BA; Schwendinger MG; Pilz A; Barrett PN; Falkner FG; Schäfer B
PLoS One; 2014; 9(2):e88340. PubMed ID: 24523886
[TBL] [Abstract][Full Text] [Related]
10. Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection.
Guo Y; He L; Song N; Li P; Sun S; Zhao G; Tai W; Jiang S; Du L; Zhou Y
Microbes Infect; 2017 Dec; 19(12):641-647. PubMed ID: 28903071
[TBL] [Abstract][Full Text] [Related]
11. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
Kamlangdee A; Kingstad-Bakke B; Osorio JE
J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
[TBL] [Abstract][Full Text] [Related]
12. Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza.
Baranowska M; Hauge AG; Hoornaert C; Bogen B; Grødeland G
Vaccine; 2015 Dec; 33(49):6988-96. PubMed ID: 26387432
[TBL] [Abstract][Full Text] [Related]
13. Hemagglutinin-based DNA vaccines containing trimeric self-assembling nanoparticles confer protection against influenza.
Qiao Y; Jin S; Nie J; Chang Y; Wang B; Guan S; Li Q; Shi Y; Kong W; Shan Y
J Leukoc Biol; 2022 Sep; 112(3):547-556. PubMed ID: 35040188
[TBL] [Abstract][Full Text] [Related]
14. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
[TBL] [Abstract][Full Text] [Related]
15. Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.
Mooney AJ; Li Z; Gabbard JD; He B; Tompkins SM
J Virol; 2013 Jan; 87(1):363-71. PubMed ID: 23077318
[TBL] [Abstract][Full Text] [Related]
16. Broadly Protective CD8
Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
J Virol; 2021 May; 95(12):. PubMed ID: 33827939
[TBL] [Abstract][Full Text] [Related]
17. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.
Wu CY; Yeh YC; Chan JT; Yang YC; Yang JR; Liu MT; Wu HS; Hsiao PW
PLoS One; 2012; 7(8):e42363. PubMed ID: 22879951
[TBL] [Abstract][Full Text] [Related]
18. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP
Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588
[TBL] [Abstract][Full Text] [Related]
19. A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice.
Zheng L; Wang F; Yang Z; Chen J; Chang H; Chen Z
BMC Infect Dis; 2009 Feb; 9():17. PubMed ID: 19216752
[TBL] [Abstract][Full Text] [Related]
20. Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza.
Shoji Y; Chichester JA; Jones M; Manceva SD; Damon E; Mett V; Musiychuk K; Bi H; Farrance C; Shamloul M; Kushnir N; Sharma S; Yusibov V
Hum Vaccin; 2011; 7 Suppl():41-50. PubMed ID: 21266846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]